Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Apr 14, 2022
Date Accepted: Aug 25, 2022
Date Submitted to PubMed: Jan 2, 2024

The final, peer-reviewed published version of this preprint can be found here:

Media Discourse Regarding COVID-19 Vaccinations for Children Aged 5 to 11 Years in Australia, Canada, the United Kingdom, and the United States: Comparative Analysis Using the Narrative Policy Framework

Chadwick VL, Saich F, Freeman J, Martiniuk A

Media Discourse Regarding COVID-19 Vaccinations for Children Aged 5 to 11 Years in Australia, Canada, the United Kingdom, and the United States: Comparative Analysis Using the Narrative Policy Framework

JMIR Form Res 2024;8:e38761

DOI: 10.2196/38761

PMID: 36383344

PMCID: 11060323

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

An analysis of the media discourse regarding COVID-19 vaccinations for children aged 5 to 11 in Australia, Canada, United Kingdom and the United States of America

  • Verity L. Chadwick; 
  • Freya Saich; 
  • Joseph Freeman; 
  • Alexandra Martiniuk

ABSTRACT

Background:

Media narratives can shape public opinion and action. Media can influence perceptions, and action regarding COVID-19 vaccines. COVID-19 has occurred at a time where ‘infodemics’ are present, and the COVID-19 response has suffered from this infodemic.

Objective:

To investigate how paediatric COVID-19 vaccine narratives have unfolded in the media of four countries USA, Australia, Canada and the UK.

Methods:

The Narrative Policy Framework (NPF) was used to guide the analyses of the major print and online news agencies’ media regarding COVID-19 vaccines for the 5 to 11 year old age group, in four English speaking countries. Data were sought using systematic searching on Factiva of four key phases of the paediatric vaccine approval and roll-out.

Results:

400 articles (287 for USA, 40 for Australia, 60 for Canada, and 13 for the United Kingdom) fit our search criteria and were included. Using the NPF, the following were identified in articles: hero, villain, victim, plot. The USA was the earliest to vaccinate children, and other countries’ media often lauded the USA for this. All four of USA, Australia, UK, and Canada used war imagery in reporting COVID-19 vaccines for children. The advent of the Omicron variant demonstrated that populations were fatigued by COVID-19 and the media reporting increasingly blamed those who were not vaccinated.

Conclusions:

Analysis of the hero, villain, victim, and plot of 400 media articles about COVID-19 vaccination in children shows that the media coverage of this pandemic relies on interpersonal narrative stories. Public health emergencies require clear, compelling and above all, accurate communication. The stories told in this pandemic are compelling because they contain the classic elements of a narrative, however they can be reductive and inaccurate.


 Citation

Please cite as:

Chadwick VL, Saich F, Freeman J, Martiniuk A

Media Discourse Regarding COVID-19 Vaccinations for Children Aged 5 to 11 Years in Australia, Canada, the United Kingdom, and the United States: Comparative Analysis Using the Narrative Policy Framework

JMIR Form Res 2024;8:e38761

DOI: 10.2196/38761

PMID: 36383344

PMCID: 11060323

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.